Clinical Trial: A Self-administered PrEP Decisional Aid for Dissemination With HIV Self-test Kits (DASH)

U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07614165) titled 'A Self-administered PrEP Decisional Aid for Dissemination With HIV Self-test Kits (DASH)' on May 08.

Brief Summary: People using HIV self-testing (HIVST) need access to quality HIV-prevention programming, including education and exploration of pre-exposure prophylaxis (PrEP) - an effective biomedical prevention tool that continues to expand in choices and access points in the US. HIVST and PrEP are both central to ending the HIV epidemic, but presently they are not linked together in a systematic way. To address the critical need for PrEP programming to accompany HIV self-testing (HIVST), our study will work with experts and HIVST us...